Inactivated Influenza A Vaccine A/H5N1

BIOLOGICAL3 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Influenza

Phase 1

H5N1 Vaccine Intramuscular Versus Intradermal in Healthy Adults

CompletedNCT00310206

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2005-07-31End: 2006-10-31Updated: 2013-06-03

Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities

CompletedNCT00311649

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2005-11-30End: 2006-09-30Updated: 2011-08-12

Higher Dose Intradermal H5 Vaccine

CompletedNCT00439335

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2007-03-31End: 2008-02-29Updated: 2013-04-09

Related Papers

Direct comparison of an inactivated subvirion influenza A virus subtype H5N1 vaccine administered by the intradermal and intramuscular routes.

2012-08-1317 citations